Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine

Journal of Infectious Diseases

Volumn 190, Issue 12, 2004, Pages 2154-2161

  Porat, Nurith ^a,b   Arguedas, Adriano ^c   Spratt, Brian G ^d   Trefler, Ronit ^a   Brilla, Eduardo ^c   Loaiza, Cecilia ^c   Godoy, Dan ^d   Bilek, Nicole ^d   Dagan, Ron ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Universidad de Ciencias Medicas   (Costa Rica)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE; VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFANT; MIDDLE EAR; MOLECULAR CLONING; MOLECULAR TYPING; NASOPHARYNX; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

CHILD; CHILD, PRESCHOOL; COSTA RICA; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFANT; ISRAEL; NASOPHARYNX; OTITIS MEDIA WITH EFFUSION; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 10444290716     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425908     Document Type: Article

References (38)

1. Ramirez M, Tomasz A. Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae. Microb Drug Resist 1999; 5:241-6.
2. Dagan R, Yagupsky P, Goldbart A, Wasas A, Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994; 13:782-6.
3. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271:1831-5.
4. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993; 168:1532-6.
5. Welby PL, Keller DS, Cromien JL, Tebas P, Storch GA. Resistance to penicillin and non-beta-lactarn antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J 1994; 13:281-7.
6. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403-9.
7. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002; 185:927-36.
8. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348:271-2.
9. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a non-avalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180:1171-6.
10. Kristinsson KG, Sigurdardottir ST, Gudnason T, et al. Effect of vaccination with octavalent protein conjugate pneumococcal vaccines on pneumococcal carriage in infants [abstract G5]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997:193.
11. Edwards KM, Wandling G, Palmer P, Decker MD. Carriage of pneumococci among infants immunized with a 9-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age [abstract 44]. In: Program and abstracts of the 37th Annual Meeting of the Infectious Diseases Society of America (Philadelphia). Alexandria, VA: Infectious Diseases Society of America, 1999:966.
12. McAllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis 2003; 188:1679-84.
13. Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis 2004; 189:385-92.
14. Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis 1998; 177:707-13.
15. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995; 171:890-6.
16. Meats E, Brueggemann AB, Enright MC, et al. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol 2003; 41:386-92.
17. NCCLS. Performance standards for antimicrobial susceptibility test: 9th information supplement [NCCLS document M100-S9]. Vol. 19, no. 1. Wayne, PA: NCCLS, 1999.
18. Jacobs MR, Bajaksouzian S, Appelbaum PC, Bolstrom A. Evaluation of the E-test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992; 15:473-8.
19. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976; 43:699-705.
20. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63.
21. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
22. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144:3049-60.
23. McGee L, McDougal L, Zhou J, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol 2001; 39:2565-71.
24. Black SB, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95.
25. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002; 21:810-5.
26. Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001; 20:1105-7.
27. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46.
28. Kyaw MH, Farley MM, Hadler J, et al. National trends in antibiotic resistant invasive pneumococcal disease in the conjugate vaccine era [abstract G-2045]. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Chicago: American Society for Microbiology, 2003:82.
29. Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003; 37:1155-64.
30. Block SL, Hedrick JA, Harrison CJ. Routine use of Prevnar in a pediatric practice profoundly alters the microbiology of acute otitis media [abstract LB3]. In: Program and abstracts of the annual meeting of the Pediatric Academic Societies (Seattle). Philadelphia: Lippincott Williams & Wilkins, 2003.
31. Greenberg D, Dagan R, Muallem M, Porat N. Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel. J Clin Microbiol 2003; 41:5541-5.
32. Arguedas A, Dagan R, Soley C, et al. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J 2003; 22:1063-8.
33. Sluijter M, Faden H, de Groot R, et al. Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life. J Clin Microbiol 1998; 36:2248-53.
34. Coffey TJ, Enright MC, Daniels M, et al. Serotype 19A variants of the Spanish serotype 23F multiresistant clone of Streptococcus pneumoniae. Microb Drug Resist 1998; 4:51-5.
35. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004; 4: 144-54.
36. Porat N, Trefler R, Dagan R. Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol 2001; 39;1827-32.
37. Tamayo M, Sa-Leao R, Santos Sanches I, Castaneda E, de Lencastre H. Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. J Clin Microbiol 1999; 37:2337-42.
38. Hanage WP, Auranen K, Syrjanen R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004; 72:76-81.